The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 403.00
Bid: 398.50
Ask: 411.00
Change: -2.50 (-0.62%)
Spread: 12.50 (3.137%)
Open: 404.00
High: 406.00
Low: 401.00
Prev. Close: 405.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

End of the Programme & 28 Apr - 6 May Transactions

6 May 2022 15:29

RNS Number : 6667K
Banco Santander S.A.
06 May 2022
 

Banco Santander, S.A., in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

End of the Buy-back Programme

Reference is made to our notice of inside information of 14 March 2022 (official registry number 1360) relating to the buyback programme of own shares (the "Buy-back Programme" or the "Programme") approved by the Board of Directors of Banco Santander, S.A. (the "Company" or "Banco Santander"). Banco Santander informs that, after the last acquisitions mentioned below, the maximum investment provided for in the Buy-back Programme, i.e. 865 million euros was reached, implying the acquisition of a total of 286,309,445 own shares, representing approximately 1.676% of the Company's share capital. The acquisition of shares under the Buy-back Programme has been communicated on a regular basis, pursuant to the provisions of article 2.2 and 2.3 of the Commission Delegated Regulation (EU) No. 2016/1052. The Buy-back Programme has therefore been terminated as a consequence of the above and in accordance with the terms set out when it was announced.

As disclosed when the Buy-back Programme was launched, its purpose was to reduce the Bank's share capital by redeeming the shares acquired under the Buy-back Programme in a capital reduction approved at the 2022 Ordinary General Shareholders' Meeting.

Last transactions executed under the Programme. 

Moreover, pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Company informs that the transactions executed as part of the Buy-back Programme, between 28 April and 6 May 2022 (both included) were as follows:

 

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (€)

28/04/2022

SAN.MC

Purchase

XMAD

13,150,000

€2.7909

29/04/2022

SAN.MC

Purchase

XMAD

13,200,000

€2.7980

02/05/2022

SAN.MC

Purchase

XMAD

11,000,000

€2.7702

03/05/2022

SAN.MC

Purchase

XMAD

12,000,000

€2.8046

04/05/2022

SAN.MC

Purchase

XMAD

13,400,000

€2.8016

05/05/2022

SAN.MC

Purchase

XMAD

13,526,000

€ 2.7724

06/05/2022

SAN.MC

Purchase

XMAD

383,445

€2.6900

TOTAL

76,659,445

 

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

 

Detailed information of the transactions carried out within the referred period is attached as Annex I.

Boadilla del Monte (Madrid), 6 May 2022

 

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 28 April and 6 May 2022 (both included)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSAFMITMTTMBPT
Date   Source Headline
23rd Mar 20181:38 pmRNS2018 AGM - Press release
15th Mar 20185:17 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSPreferred securities contingently convertible
12th Mar 20189:31 amRNSPre Stabilisation Notice
1st Mar 20186:03 pmRNSDirector/PDMR Shareholding
1st Mar 20186:02 pmRNSDirector/PDMR Shareholding
21st Feb 20185:03 pmRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
19th Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Feb 20184:38 pmRNS2018 Notice of AGM
16th Feb 20184:34 pmRNS2017 Annual Financial Report
14th Feb 20187:01 amRNSAnnouncement: Notice of AGM
31st Jan 20187:00 amRNS2017 results report & analyst presentation
31st Jan 20187:00 amRNS2017 results press release
30th Jan 20182:59 pmRNS2017 results presentation
16th Jan 20184:44 pmRNSDirector/PDMR Shareholding
16th Jan 20184:41 pmRNSDirector/PDMR Shareholding
16th Jan 20184:40 pmRNSDirector/PDMR Shareholding
28th Dec 20173:50 pmRNSDirector/PDMR Shareholding
20th Dec 20177:18 amRNSInformation on dividends
18th Dec 20175:03 pmRNS2018 prudential minimum capital requirements
15th Dec 201712:15 pmRNSDirector/PDMR Shareholding
15th Dec 20177:33 amRNSFidelity Bonds: Results of the public tender offer
14th Dec 20177:29 amRNSAgreement with Deutsche Bank, A.G.
29th Nov 20177:00 amRNSChanges approved by the Board of Directors
24th Nov 20177:00 amRNSDirector/PDMR Shareholding
15th Nov 20174:44 pmRNSDirector/PDMR Shareholding
15th Nov 20174:40 pmRNSDirector/PDMR Shareholding
15th Nov 20174:39 pmRNSDirector/PDMR Shareholding
10th Nov 20173:29 pmRNSDirector/PDMR Shareholding
10th Nov 20173:28 pmRNSDirector/PDMR Shareholding
10th Nov 20173:28 pmRNSDirector/PDMR Shareholding
10th Nov 20173:25 pmRNSDirector/PDMR Shareholding
10th Nov 20173:23 pmRNSDirector/PDMR Shareholding
10th Nov 20173:23 pmRNSDirector/PDMR Shareholding
10th Nov 20173:22 pmRNSDirector/PDMR Shareholding
10th Nov 20173:21 pmRNSDirector/PDMR Shareholding
10th Nov 20173:19 pmRNSDirector/PDMR Shareholding
10th Nov 20173:18 pmRNSDirector/PDMR Shareholding
7th Nov 20177:00 amRNSInformation on Santander Dividendo Eleccion
26th Oct 20177:00 amRNS3Q2017 results press release
26th Oct 20177:00 amRNS3Q2017 results report, presentation & charts
25th Oct 20173:02 pmRNS3Q2017 results presentation
17th Oct 20174:54 pmRNSDirector/PDMR Shareholding
17th Oct 20174:54 pmRNSDirector/PDMR Shareholding
17th Oct 20174:54 pmRNSDirector/PDMR Shareholding
17th Oct 20174:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.